RGA Price Prediction Next Week
Technical Analysis: Based on recent price action, RGA shows a strong upward momentum after the announcement of a significant reinsurance transaction with Equitable Holdings.
The stock has risen 6.5% to $201.79 following the reinsurance transaction announcement. Key technical levels show:
- Support: $200.55
- Current price: $202.69
- Resistance: $214.21
News Impact Analysis:
- Major Reinsurance Deal:
- RGA to reinsure $32 billion of Equitable's life insurance products
- Expected deployment of $1.5 billion capital
- Transaction to contribute:
- $70 million to adjusted operating income (2025)
- $160-170 million (2026)
- ~$200 million annually thereafter
- Debt Offering:
- Priced $700M in 6.650% subordinated debentures
- Due 2055, issue price 100%
- Expected completion: March 3, 2025
- Credit Rating Update:
- Moody's affirmed ratings but revised outlook to negative
- Concerns over capital adequacy following the Equitable deal
Price Forecast (Next Week): Based on technical indicators and recent developments:
- Short-term target: $214-215 range
- Expected support level: $200.55
- Volatility range: 2.60% daily average
Recommendation: BUY Rationale:
- Strong fundamental catalyst with Equitable deal
- Clear earnings visibility for next several years
- Technical momentum remains positive
- However, maintain stop-loss at $198 (below short-term moving average support)
RGA Similar Chart Price Prediction
The price of RGA is predicted to go up -4.92%, based on the high correlation periods with LCTX. The similarity of these two price pattern on the periods is 98.69%.
RGA
LCTX
Down: -4.92%Similarity: 98.69%
RGA Revenue Forecast
RGA EPS Forecast
RGA FAQs
What is bull’s view on RGA?
What is bear's view on RGA?
What is RGA revenue forecast for next quarter？
What is RGA eps forecast for next quarter？
RGA Analyst's Forecast
John Barnidge
Piper Sandler
Buy
2025-02-10
Price Target
$252 → $242
Upside
+21.57%
Piper Sandler lowered the firm's price target on Reinsurance Group to $242 from $252 and keeps an Overweight rating on the shares. The firm says Q4 had quite a bit of noise, with lower earnings due to claims experience in international markets. There were additional pricing actions taken in U.S. traditional to improve profitability that has often led to additional liability opportunities.
Jimmy Bhullar
JP Morgan
Hold
2025-01-07
Price Target
$227 → $232
Upside
+4.58%
Alex Scott
Barclays
Buy
2025-01-06
Price Target
$255 → $252
Upside
+13.6%
